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Background: You-Gui pills (You-Gui-Wan; YGW) can promote T lymphocyte proliferation and differentiation, and
restore Th1/Th2 balance in the treatment of asthma, but their mechanism of action is not fully known. This study aims to
explore whether YGW can induce histone deacetylation or acetylation in memory T lymphocytes (Tm) for improvement
of airway inflammation in asthma.
Methods: CD4+CD45RBlow cells, as Tm, were obtained by magnetic-activated cell sorting and flow cytometry from the
spleens of BALB/c mice with ovalbumin (OVA)-induced asthma. Tm were cocultured with hydrocortisone (CORT; 1000 nM),
serum containing low (0.225 g/kg), moderate (0.9 g/kg), or high (3.6 g/kg) doses of YGW, or medium only, and then
adoptively transferred into naïve mice (n = 5 per group). Recipient mice were challenged with aerosolized OVA. The levels
of IL-4, IL-5, IL-13, and IFN-γ in culture supernatants and bronchoalveolar lavage fluid (BALF) from the OVA-challenged
mice were measured by ELISA. Histone deacetylase (HDAC) and histone acetyltransferase (HAT) activities and protein
expressions of T-bet, GATA-3, and HDAC1–11 in lung tissue were measured by western blotting analyses. The alveolar
eosinophilic inflammation index (AEII) was evaluated in the lungs of adoptive transfer recipient mice.
Results: YGW reduced inflammation and eosinophil infiltration into the lung tissues as evidenced by histology, with
similar effects to those of CORT. High-, moderate-, and low-YGW increased HDAC (P < 0.0001, P = 0.0009 and P = 0.0253
respectively) and decreased HAT (P = 0.0001, P = 0.0000 and P = 0.0039, respectively) activities in dose-dependent manners
in the lung tissues of adoptive transfer recipient mice. Increased histone deacetylation of Tm by YGW reduced the AEII
by reducing GATA-3 (P = 0.014),IL-4 (P = 0.0004), IL-5 (P = 0.0067), and IL-13 (P = 0.0002), and inducing IFN-γ release
(P = 0.0375). Moreover, YGW reduced inflammatory cytokines such as IL-4, IL-5, and IL-13 by upregulating the activities of
HDAC7 (P = 0.003)/10 (P = 0.003), HDAC11 (P < 0.0001), and HDAC9–11 (P < 0.0001, P < 0.0001 and P < 0.0001, respectively),
respectively, and increased IFN-γ release by increasing HDAC9 (P < 0.0001).
Conclusions: Histone deacetylation of Tm was observed during alleviation of allergen-induced eosinophilic airway
inflammation in asthma by YGW.* Correspondence: wcums-respiration@hotmail.com
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Figure 1 Flow chart outlining the study protocol for OVA sensitization
and challenge and/or adoptive transfer. i.p., intraperitoneal injection.
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Asthma is an inflammatory disease of the airways that
involves multiple inflammatory cells (T lymphocytes and
eosinophils) and inflammatory mediators [1,2]. Allergic
asthma is considered to be a Th2-driven inflammatory
disease [3]. Therefore, drugs that can suppress Th2 cyto-
kine production are potentially therapeutic [4].
Histone acetylation is an epigenetic modification that
maintains pre-established patterns of cytokine memory
[5]. Zhang et al. [6] identified T cells with a memory-like
phenotype during fetal development, which displayed a
large variety of inflammatory effector functions associated
with CD4+ T helper (Th) cells at birth. Importantly for
immune memory, the histone modification profile at a
given gene locus could be inherited through mitosis [7,8].
Histone acetyltransferases (HATs) and histone deacety-
lases (HDACs) regulate chromatin structure and affect
inflammatory gene expressions [9]. The extents of acetyl-
ation of core histones might reflect the balance between
the opposing activities of HATs and HDACs [10].
Acetylation of histone tails is involved in the activation
of gene transcription [11] and enhances chromatin ac-
cessibility [10]. Su et al. [12] found that endogenous
HDAC activity was involved in maintaining the balance
of pre-established Th1-like and Th2-like responses,
thereby inhibiting excessive Th2 immunity.
Although corticosteroids and β2-agonists can im-
prove asthma symptoms, there are known side effects,
such as disturbance of adrenal function and generalized
immune suppression, particularly in children [13].
Some Chinese medicines promote T lymphocyte prolif-
eration and transformation, and adjust imbalances in
Th1 and Th2 responses [14]. You-Gui pills (You-Gui-Wan;
YGW) have efficacy for the treatment and prevention
of asthma [15] by enhancing the immune system’s
ability [16]. However, the mechanisms underlying
the effects of YGW in asthma treatment are still
unknown.
This study aims to explore whether YGW could in-
duce histone deacetylation or acetylation in memory T




Male BALB/c mice (6–8weeks of age and free of
murine-specific pathogens) were purchased from the La-
boratory Animal Center of West China School of Medi-
cine (China). The mice were housed throughout the
experiments in a laminar flow cabinet. The animal study
protocols were approved by the Institutional Animal
Care Committee of West China Hospital, Sichuan
University, China (Supplementary file 01). The flow
chart for this study protocol was shown in Figure 1.Serum preparation containing YGW
YGW capsules (batch number: 961015) were pur-
chased from YinTao Pharmaceutics Ltd. (China). YGW
capsules (4,500.00 mg/capsule) were dissolved in saline
(473.68 mg/mL) and stored at −20°C before adminis-
tration to mice. Thirty-six mice were randomly divided
into YGW (n = 12) and sham control (n = 24) groups,
and then gavaged (3.6 g/kg body weight) continuously
for 5 days with YGW or saline (200 μL), respectively.
The mice were anesthetized at 2 h after the last gavage,
and blood was withdrawn and centrifuged (H2050R;
Xiangyi, China) at 12,000 rpm (10,005 × g) for 4 min at
4°C. The supernatant, designated the decoction serum,
was inactivated for 30 min at 56°C and stored at −80°C
until use.
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Mice were sensitized and challenged with ovalbumin
(OVA) (Sigma-Aldrich, USA) as previously described
[17]. Briefly, mice were sensitized on days 1 and 14 by
intraperitoneal injection of 20mgof OVA emulsified in
1 mg of aluminum hydroxide (Longsheng Chemical
Co. Ltd., China) in a total volume of 200 μL. On days
21, 22, and 23 after the initial sensitization, the mice
were challenged for 30 min with an aerosol of 30 μg/mL
OVA in PBS by placing the mice in a 20 × 30 × 50-cm
plexiglass chamber connected to an ultrasonic nebulizer
(Berry Co. Ltd., Germany) that generated an aerosol mist
with a pumping volume of 6 L/min.
Isolation and purification of CD4+CD45RBlow T cells
Mice were euthanized at 24 h after the last OVA challenge,
and their spleens were removed aseptically. Lympho-
cytes were obtained from the spleens using an EZ-Sep™
Mouse1 × Lymphocyte Separation Kit (DakeweiBiotechFigure 2 Flow cytometry to isolate CD4+CD45RBlow cells. (A) Lymphocytes
CD4+CD45RBhigh cells (P5). (D) Proportion of cells in each group.Company, China). CD4+ T lymphocytes were negatively
selected by magnetic-activated cell sorting (Dynal® Mouse
CD4 Negative Isolation Kit, Invitrogen Dynal, USA) ac-
cording to the manufacturer’s instructions.
CD4+CD45RBlow T cells were obtained by flow cytometry
(FC 500 Series Flow Cytometry System; Beckman Coulter,
USA) as previously described [18]. Briefly, CD4+ T cells
were incubated with FITC-conjugated anti-CD4 (Clone
GK1.5; BD Pharmingen™, USA) and PE-conjugated anti-
CD45RB (Clone 16A; BD Pharmingen™, USA) antibodies in
PBS for 30 min at 4°C, and washed twice in PBS. The cells
were then sorted by flow cytometry using a FACS Vantage
SE Cell Sorter (Beckman Coulter Company, USA)
(Figure 2). The purity of CD4+CD45RBlow cells was >95%.
Cell culture, interventions, and cytokine analysis
Isolated CD4+CD45RBlowcells were cultured in RPMI 1640
medium (Gibco, USA) at 1.5× 105 cells/mL in 24-well
round-bottom plates (BD,USA) in triplicate. The cells were(P1). (B) CD4+ T lymphocytes (P2). (C) CD4+CD45RBlow cells (P3) and
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of penicillin and streptomycin (Shandong Lukang
Pharmaceutical Company, China), and various interven-
tions at 37°C in a 5% CO2 incubator for 36 h. The inter-
ventions were as follows: (1) high dose of YGW (3.6 g/kg;
H-YGW), given as 200 μLof YGW serum, comprising 40
times the equivalent clinical dose given to adults; (2) mod-
erate dose of YGW (0.9 g/kg; M-YGW), given as 50 μL of
YGW serum and 150 μL of blank serum; (3) low dose of
YGW (0.225 g/kg; L-YGW), given as 12.5 μL of YGW
serum and 187.5 μL of blank serum; (4) hydrocortisone
(CORT), given as hydrocortisone (1000nM) (Sigma, USA)
and 200 μL of blank serum; and (5) control group (OVA),
given as 200 μL of blank serum without any drug interven-
tion. After culture, the supernatants were kept at −80°C
until analysis by ELISA (Senxiong Biotech, China) for IL-4,
IL-5, IL-13, and IFN-γ, and the CD4+CD45RBlow cells were
used for adoptive transfer to naïve mice.
Adoptive transfer, challenge, bronchoalveolar lavage, and
cytokine analysis
The CD4+CD45RBlow cells in each intervention were re-
suspended in 250 μL of PBS, divided into five equivalent
parts, and adoptively transferred to five naïve mice (ap-
proximately 0.9 × 105 cells/mouse). The adoptive transfer
was performed as described in our previous report [19].
Briefly, anesthetized and tracheostomized naïve mice were
injected with 50 μL of CD4+CD45RBlow cell suspension
using a syringe. At 24 h after adoptive transfer, the mice
were challenged for 30 min with OVA.
Bronchoalveolar lavage was performed at 24 h after
the last challenge. The left lungs were lavaged three
times with 1 mL of sterile normal saline, as previously
described [20]. Briefly, the mice were euthanized with
sodium pentobarbitone (100 mg/kg body weight, admin-
istered intraperitoneally). The chest cavity was exposed
for expansion, and the trachea was cannulated with a
20-gauge catheter that was secured with a ligature.
Lavage of the left lung was performed using a 1-mL
aliquot of saline. A total of three lavages were performed
after tying off the right lung at the mainstem bronchus.
In all mice, the recovery of the lung lavage fluid was 80%
or greater. The recovered fluid was centrifuged at
1,200 rpm (273 × g) and 4°C for 5 min. The supernatants
of the bronchoalveolar lavage fluid (BALF) were kept at
−80°C until analysis by ELISA for IL-4, IL-5, IL-13, and
IFN-γ (Senxiong Biotech, China).
Lung tissue pathology and alveolar eosinophilic
inflammation index (AEII)
The right lower lung tissues around the main bronchus
were cut, inflated with 4% formaldehyde solution, and em-
bedded in paraffin. Cryostat sections (4 μm) of the tissues
were cut and air-dried. Morphological observations wereperformed after sections were stained with hematoxylin
and eosin (HE), and asthma-like inflammation features
were assessed in each section under 400× magnification.
The AEII was assessed as previously described [19].
Briefly, the eosinophilic inflammation intensity in the al-
veolar area was calculated as the number of eosinophils
per alveolar area. Three sections were arbitrarily selected
from each group of mice and three alveolar regions in
each section were analyzed at high magnification, while
trying to avoid blood vessels and bronchioles. The eosino-
phils in each zone were counted, and the area of each al-
veolar region was determined using Image-Pro Plus 4.5
software (Media Cybernetics, USA). These data were used
to calculate the average density of eosinophils in each
group, for measurement of the eosinophilic inflammation
intensity. The AEII was calculated as the inflammation in-
tensity ratio of each group versus naïve mice.
HDAC and HAT activities
The HDAC and HAT activities in the right upper lung tis-
sues were measured using colorimetric activity assay kits
(Colorimetric HDAC Activity Assay Kit [Catalog #K331-
100); HAT Activity Colorimetric Assay Kit [Catalog
#K332-100); BioVision Inc.,USA], in accordance with the
manufacturer’s protocols. Briefly, an HDAC colorimetric
substrate was incubated with 80 μg of total nuclear ex-
tracts from lung tissues for 60 min at 37°C. Following the
incubation, lysine-developer solution was added to gener-
ate a measurable chromophore that was analyzed by the
absorbance at 405 nm using an ELISA microplate reader
(Bio-Rad Laboratories, USA). HeLa cells nuclear extracts
(4 μg) were used as a positive control. An HDAC inhibitor,
trichostatin A, was used to demonstrate the specificity of
the deacetylation activities. For the HAT activity assay, an
active nuclear extract as a positive control and acetyl-CoA
as a cofactor were utilized. Total nuclear extracts (50 μg)
were incubated with acetyl-CoA at 37°C for 120 min.
Acetylation of the peptide substrate by active HAT
released the free form of CoA, which then served as an
essential coenzyme for producing NADH. The produced
NADH was detected spectrophotometrically upon reacting
with a soluble tetrazolium dye. The activity was analyzed by
the absorbance at 440 nm using the above-described ELISA
plate reader.
Western blot analysis
The right upper lung tissues were homogenized in the
presence of protease inhibitors, and the protein concentra-
tions were determined using NE-PER® nuclear and cyto-
plasmic extraction reagents (Pierce Biotechnology, USA).
The total proteins (50 μg) were loaded onto SDS-PAGE
gels. After electrophoresis at 120 V for 90 min, the sepa-
rated proteins were transferred to polyvinylidene difluor-
ide membranes using a wet transfer method (250 mA for
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fat dry milk in Tris-buffered saline containing 0.1% Tween
20 for 1 h, and the membranes were then incubated over-
night at 4°C with anti-GATA-3, anti-T-bet (Santa Cruz
Biotechnology Inc., USA), or anti-HDAC1–11 (HDAC
Family Antibody Set; BioVision, USA) primary antibodies.
Horseradish peroxidase-conjugated anti-rabbit IgG was
used to detect binding of the primary antibodies. The
membranes were stripped and reprobed with an anti-actin
primary antibody (Sigma-Aldrich, USA) to verify equal
protein loading in each lane. The binding of the specific
antibodies was visualized by exposure to photographic
film. The densities of the stained bands for T-bet, GATA-
3, and HDAC1–11 relative to the staining band for β-actin
were quantified with Quantity ONE densitometry software
(PDI Imageware Systems, USA).
Statistical analysis
All data were presented as mean ± SD. Differences
among data were analyzed by one-way analysis of vari-
ance (ANOVA). For comparisons of data that were not
normally distributed, a Mann–Whitney U-test was per-
formed. Student-Newman-Keuls (SNK) test was used for
multiple group comparisons. The dose-dependent man-
ner was visually determined. Associations were investi-
gated by Spearman correlation analysis. A double-sided
P value of < 0.05 was considered statistically significant.
All statistical analyses were performed using Stata ver-
sion 11.0 (Stata Corp LP, USA).
Results
Cytokines in cell culture supernatants and BALF
Tm were cocultured with CORT, serum containing low,
moderate, or high doses of YGW, or medium only. The
levels of IL-4, IL-5, IL-13, and IFN-γ in culture superna-
tants and BALF from OVA-challenged mice were mea-
sured by ELISA (Table 1). CORT significantly reduced theTable 1 IL-4, IL-5, IL-13, and IFN-γ levels (pg/mL) in cell cultur
Cytokines You-Gui-Wan
H-YGW M-YGW
Cell culture n = 3 n = 3
IL-4 9.9 ± 2.4**† 17.4 ± 1.9**
IL-5 14.2 ± 2.0** 17.8 ± 9.3
IL-13 25.4 ± 16.2* 35.3 ± 19.4
IFN-γ 3.4 ± 0.2* 2.9 ± 0.5
BALF n = 5 n = 5
IL-4 18.6 ± 6.8** 27.7 ± 11.0
IL-5 12.4 ± 5.2** 18.7 ± 5.3
IL-13 9.1 ± 1.5** 17.5 ± 2.8**
IFN-γ 2.9 ± 0.2* 2.7 ± 0.4
*P <0.05, **P < 0.01, compared with OVA. †P <0.05, compared with CORT.IL-4 (P = 0.0161), IL-5 (P = 0.0059), and IL-13 (P = 0.0005)
levels. H-YGW, M-YGW and L-YGW significantly reduced
the IL-4 (P = 0.0002, P = 0.0008 and P = 0.0015, respect-
ively) and IL-5 (P = 0.0004, P = 0.0008 and P = 0.0015,
respectively) levels. Compared with CORT, the IL-4 level
in H-YGW cultures was decreased to a greater extent
(P = 0.0167). There were dose-dependent responses to
YGW in reducing the IL-4, IL-5, and IL-13 levels. The
IFN-γ level in the H-YGW cultures was increased com-
pared with the OVA cultures (P = 0.0164).
The IL-4, IL-5, IL-13, and IFN-γ levels in BALF after
adoptive transfer are shown in Table 1. CORT significantly
reduced the IL-4 (P = 0.0002), IL-5 (P = 0.0008), and IL-13
(P = 0.0023) levels, H-YGW significantly reduced the IL-4
(P = 0.0004), IL-5 (P = 0.0067) and IL-13 (P = 0.0002) levels,
but there were no differences in the levels of these cyto-
kines between YGW and CORT (all P > 0.05). The levels of
IL-4, IL-5, and IL-13 showed dose-dependent responses to
YGW. The IFN-γ level in the H-YGW group was much
higher than that in the OVA group (P = 0.0375).HDAC and HAT activities
The HDAC and HAT activities in the lung tissues of mice
after adoptive transfer are shown in Figure 3. The HDAC
activities and ratios of HDAC to HAT activity (HDAC/
HAT) in the H-YGW (P = 0.0004 and P = 0.0002 respect-
ively), M-YGW (P = 0.0009 and P = 0.0001 respectively),
L-YGW (P = 0.0253 and P = 0.0053 respectively) and
CORT groups (P = 0.0037 and P = 0.0000 respectively)
were significantly higher than those in the OVA group. By
contrast, the HAT activities in the H-YGW (P = 0.0067),
M-YGW (P = 0.0000), L-YGW (P = 0.0039) and CORT
(P = 0.0015) groups were significantly decreased compared
with the OVA group. The HDAC activity, HAT activity,
and HDAC/HAT ratio showed dose-dependent responses
to YGW.e supernatants and BALF
CORT OVA
L-YGW
n = 3 n = 3 n = 3
17.5 ± 2.5** 19.4 ± 4.6* 28.5 ± 1.7
21.2 ± 6.4 15.0 ± 4.4** 26.6 ± 1.2
40.2 ± 18.9 15.9 ± 2.8* 45.5 ± 5.2
2.8 ± 0.2 3.1 ± 0.2 2.9 ± 0.3
n = 5 n = 5 n = 5
21.3 ± 5.0** 24.2 ± 3.4** 36.4 ± 3.4
23.3 ± 5.4 14.1 ± 2.5** 19.9 ± 1.2
32.8 ± 5.4 9.9 ± 7.5** 27.5 ± 6.8
2.4 ± 0.2 2.4 ± 0.2 2.6 ± 0.3
Figure 3 Total HDAC activity (μM/μg) (A), HAT activity (μM/μg) (B), and HDAC/HAT ratio (C) in the lung tissues of mice after adoptive transfer. *P <0.05,
**P<0.01 compared with OVA. ‡P <0.01, compared with CORT. Student-Newman-Keuls (SNK) test was used for multiple group comparisons.
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lung tissue
The expressions of GATA-3 and T-bet proteins in the
lung tissues of mice after adoptive transfer are shown in
Figure 4. The GATA-3 expression in the YGW group was
significantly lower than that in the OVA group (P = 0.014),
but the observed downregulation in the CORT group did
not reach statistical significance (P = 0.062). There were
no significant differences in T-bet expression between the
YGW, CORT, and OVA groups.
The expressions of HDAC7, HDAC9, HDAC10, and
HDAC11 in the lung tissues of mice after adoptive trans-
fer are shown in Figure 5. The expressions of HDAC7,
HDAC10, and HDAC11 in the H-YGW (P = 0.0030,
P = 0.0000 and P = 0.0000 respectively) and CORT
groups (P = 0.0210, P = 0.0010 and P = 0.0333 respectively)
were significantly upregulated compared with those in the
OVA group. The HDAC9 expression in the H-YGW
and M-YGW group, but not in the CORT group, was
much higher than that in the OVA group (P < 0.0010,
P = 0.0152 and P = 0.8955, respectively). The expressions
of HDAC7 and HDAC9–11 showed dose-dependent re-
sponses to YGW. The expressions of HDAC1–6 and
HDAC8 are shown in Table 2. There were no significant
differences in the expressions of these proteins between
the experimental groups (all P > 0.05).Lung histopathology and AEII
The lung tissues in the OVA group were characterized
by wider alveolar interstitium, congestion, and edema,
with many infiltrating eosinophils and mononuclear cells
including lymphocytes (Figure 6A). Compared with the
OVA group, inflammation was reduced in the lungs of
the H-YGW (Figure 6B), M-YGW (Figure 6C), L-YGW
(Figure 6D), and CORT (Figure 6E) groups. These findings
were reflected in the AEII values (Figure 6F): H-YGW
(0.74 ± 0.19, P = 0.0146), M-YGW (0.57 ± 0.39, P = 0.0207),
L-YGW (0.70 ± 0.18, P = 0.0069), CORT (0.66 ± 0.11,
P = 0.0010) compared with OVA (1.02 ± 0.14). There were
no differences in the AEII values among the H-YGW,
M-YGW, L-YGW, and CORT groups (all P > 0.05).
Relationships between cytokines, HDAC expression,
and AEII
There were negative associations between HDAC activ-
ity and IL-4 (rho = −0.65, P = 0.009), IL-5 (rho = −0.59,
P = 0.022), and IL-13 (rho = −0.65, P = 0.009) in BALF.
There was a positive correlation between HAT activity
and IL-13 in BALF (rho = 0.61, P = 0.015). These rela-
tionships between cytokines and HDAC or HAT activity
also existed in cell cultures. Furthermore, the IFN-γ
level in cell cultures was positively correlated with HDAC
activity (rho = 0.59, P = 0.021). Significant correlations were
Figure 4 GATA-3 (A) and T-bet (B) protein expressions, normalized by β-actin expression (C), in the lung tissues of mice after adoptive transfer. *P <0.05,
compared with OVA. Student-Newman-Keuls (SNK) test was used for multiple group comparisons.
Zhang et al. Chinese Medicine  (2015) 10:9 Page 7 of 11found between IL-4 in BALF and HDAC5 (rho = −0.53,
P = 0.0419), HDAC7 (rho = −0.68, P = 0.0055), and
HDAC10 (rho = −0.61, P = 0.0167), IL-5 in BALF and
HDAC11 (rho = −0.51, P = 0.0501), IL-13 in BALF and
HDAC9–11 (rho = −0.62, P = 0.0141; rho = −0.51, P =
0.0519 and rho = −0.71, P = 0.0031 respectively), and
IFN-γ and HDAC9 (rho = 0.56, P = 0.0308).
There were no correlations between T-bet/GATA-3
and IL-4, IL-5, IL-13, and IFN-γ. However, the GATA-3
protein level was negatively associated with HDAC
activity (rho = −0.51, P = 0.05), HDAC8 (rho = −0.61,
P= 0.002), HDAC9 (rho=−0.56, P = 0.004), and HDAC11
(rho=−0.60, P= 0.002). T-bet expression was negatively as-
sociated with HAT activity (rho=−0.58, P= 0.023), but posi-
tively associated with HDAC1–4 (rho= 0.52, P= 0.0071;
rho= 0.59, P = 0.0017; rho= 0.43, P= 0.0330 and rho= 0.65,
P= 0.0004 respectively), HDAC7 (rho= 0.44, P= 0.0293, and
HDAC8 (rho= 0.63, P= 0.0008) .
HDAC activity was negatively associated with AEII
(P= 0.05), but positively associated with HAT activity
(P= 0.021). HDAC2–4 (rho=−0.50, P= 0.0361; rho =−0.61,
P= 0.0201 and rho=−0.53, P= 0.0502 respectively) and
HDAC10 (rho=−0.63, P= 0.0150) were negatively associ-
ated with AEII .
Discussion
YGW, which is similar to CORT, dose-dependently in-
creased HDAC activity, but reduced HAT activity in the
lung tissues of asthmatic mice, and alleviated alveolareosinophilic inflammation in their lungs by reducing
GATA-3, IL-4, IL-5, and IL-13, and inducing IFN-γ
release. Moreover, YGW reduced the production of inflam-
matory cytokines such as IL-4, IL-5, and IL-13 by increas-
ing the corresponding activity of HDAC7/10, HDAC11,
and HDAC9–11, respectively. YGW increased IFN-γ
release by increasing HDAC9. Therefore, YGW appears to
promote HDAC7- and HDAC9–11-induced histone deace-
tylation of Tm, leading toprotection against lung inflam-
mation and eosinophilic infiltration.
Elevated levels of serum IgE are correlated with the
incidence or severity of asthma. Undetectable serum total
IgE may serve as a marker for immune dysregulation and
autoimmunity [22]. Lin et al. [15] revealed that YGW
treatment significantly decreased serum total IgE and pos-
sessed anti-inflammatory effects including reductions in
total cell numbers and in the percentages of macrophages
and eosinophils in BALF of Dermatophagoides pteronyssi-
nus-induced asthma. Blood and tissue eosinophilia are
hallmarks of allergic rhinitis, atopic dermatitis, and atopic
asthma. Eosinophils are key effector cells in the pathogen-
esis of allergic disease [23] and are recruited from the
circulation to inflammatory tissues in response to allergic
stimuli [24]. In the present study, we chose the AEII as an
index of inflammation, and found that YGW could reduce
lung inflammation and eosinophil infiltration into the lung
tissues to improve the asthmatic condition.
T cells with a Th2-like phenotype are involved in or-
chestrating the asthmatic inflammatory responses [25].
Table 2 HDAC1–6 and HDAC8 protein expressions in lung
tissues after adoptive transfer







(n = 5) (n = 5)
HDAC1 0.90 ± 0.42 1.51 ± 1.02 0.84 ± 0.32 1.12 ± 0.89 0.45 ± 0.27
HDAC2 0.89 ± 0.41 1.16 ± 0.47 0.97 ± 0.52 1.14 ± 0.45 0.42 ± 0.27
HDAC3 0.73 ± 0.32 0.78 ± 0.35 0.88 ± 0.43 0.72 ± 0.42 0.37 ± 0.23
HDAC4 0.41 ± 0.20 0.77 ± 0.41 0.65 ± 0.24 0.59 ± 0.17 0.31 ± 0.22
HDAC5 0.53 ± 0.22 0.61 ± 0.25 0.60 ± 0.23 0.52 ± 0.19 0.28 ± 0.09
HDAC6 0.68 ± 0.16 1.01 ± 0.31* 0.77 ± 0.11 0.75 ± 0.36 0.41 ± 0.13
HDAC8 0.69 ± 0.15 0.81 ± 0.49 0.69 ± 0.37 0.61 ± 0.41 0.28 ± 0.19
*P <0.05, compared with OVA.
Figure 5 HDAC7 (A), HDAC9 (B), HDAC10 (C), andHDAC11 (D) protein expressions, normalized by β-actin expression (E), in the lung tissues of mice after
adoptive transfer, determined by western blotting. *P <0.05, **P< 0.01, compared with OVA.†P <0.05, compared with CORT. Student-Newman-Keuls (SNK)
test was used for multiple group comparisons.
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CD4+CD25+ T cells in BALF, suggesting that YGW might
block this feedback system and shift Th2-dominance by
increasing IL-12 levels. Notably, the important regulators
of eosinophil trafficking are Th2 cytokines such as IL-4,
IL-5, and IL-13 [26]. In our study, we demonstrated that
YGW alleviated alveolar eosinophilic inflammation by
reducing GATA-3, IL-4, IL-5, and IL-13, and inducing
IFN-γ release. Suppression of these cytokines might re-
duce eosinophil infiltration into the alveolar spaces,
thereby alleviating allergic asthmatic inflammation.
Su et al. [12] revealed that endogenous HDAC activity
was involved in maintaining the balance of pre-
established Th1-like and Th2-like responses, and inhibit-
ing excessive Th2 immunity. In our study, we found that
YGW dose-dependently increased HDAC activity and
reduced HAT activity in the lung tissues of asthmatic
mice, consistent with the results of Haczku et al. [27],
Figure 6 Pathological changes inthe lung tissues in the five groups of asthmatic mice after adoptive transfer (400×). (A) OVA group. (B) H-YGW
group. (C) M-YGW group. (D) L-YGW group. (E) CORT group. (F) Alveolar eosinophilic inflammation index. *P <0.05, compared with OVA. Student-
Newman-Keuls (SNK) test was used for multiple group comparisons.
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IL-4 and IL-5 in the induction of eosinophilic inflamma-
tion in our model. Therefore, we propose that YGW
treatment reduced lung inflammation by downregulating
Th2 cytokines. In addition, we found clear negative asso-
ciations between HDAC expressions and the levels of
IL-5 in cell cultures and BALF. IL-5 induces selective
eosinophil (as opposed to neutrophil) recruitment [28]
and activation [29], and is the only known cytokine to
promote the terminal differentiation of eosinophil pre-
cursors and enhance survival [30].
The metal-dependent HDAC enzymes are grouped into
class I, class II, and class IV on the basis of their homology
to yeast proteins. Class I is comprised of HDAC1,
HDAC2, HDAC3, and HDAC8, which are predominantly
localized in the nucleus, have a ubiquitous tissue distribu-
tion, and play critical roles in cell survival and prolifera-
tion [31]. Class II enzymes are further subdivided into
class IIa (HDAC4, HDAC5, HDAC7, and HDAC9) and
class IIb (HDAC6 and HDAC10) [32]. Little is known
about the function of HDAC10. Similarly, not much is
known about HDAC11, the sole member of the class IV
enzymes [33]. There is evidence that the different HDACs
target different patterns of acetylation, and therefore regu-
late different types of genes [34]. In biopsies from patients
with asthma, there was an increase in HAT activity and areduction in HDAC activity, thereby favoring increased in-
flammatory gene expressions [35]. In our study, YGW
reduced the inflammatory cytokines IL-4, IL-5, and IL-13
by increasing the activity of HDAC7/10, HDAC11, and
HDAC9–11, respectively.
The findings that endogenous HDAC activity markedly
influenced both the intensity and nature of immune re-
sponses suggest a potential mechanism through which
treatment can alter the balance of Th1/Th2 recall re-
sponses by modulating endogenous HDAC activity [26].
Reactive oxygen species from cigarette smoke also reduce
HDAC2 expression and activity, enhance cytokine expres-
sion, and inhibit glucocorticoid action in alveolar macro-
phages [36]. In severe asthma and asthmatics who smoke,
HDAC2 is reduced, thus preventing corticosteroids from
suppressing inflammation [37]. It was suggested that
HDAC2 may be a novel target for the development of new
anti-inflammatory treatments [37]. In our study, there
were no differences in HDAC2 activity between the ex-
perimental groups, probably because our asthma was not
severe and did not feature neutrophilic inflammation [38].
However, YGW did promote histone deacetylation of Tm
by HDAC7 and HDAC9–11, leading to protection against
eosinophil infiltration and lung inflammation.
GATA-3 is essential for T-cell development and the
induction of Th2 cytokines (IL-4, IL-5, and IL-13). It is
Zhang et al. Chinese Medicine  (2015) 10:9 Page 10 of 11also an important transcription factor in the pathogenesis
of asthma [39]. Ectopic expression of GATA-3 increased
the expression of Th2-associated cytokines and decreased
the expression of Th1-associated cytokines [40]. HDAC9-
deficient mice exhibit increased Th2 polarization, with
HDAC9 deficiency being associated with global site-specific
lysine histone acetylation at H3 (H3K9, H3K14, and
H3K18) that was localized to the IL-4 promoter [41]. In
addition, HDAC9 has effects on Foxp3 expression and
function (regulatory T cells) that suppress the production
of Th2 cytokines [42]. Han et al. [43] found that transcrip-
tional activation of the IL-5 gene by trichostatin A was
achieved by affecting HDAC function on the IL-5promoter
via transcription factors. Salidroside, a synthetic compound
originally from Chinese herbal medicines, improved the
progression of asthma, and could be used as a therapy for
patients with allergic asthma by regulating the GATA-3/T-bet
balance [44]. In our study, we did not find any correlations
between T-bet and GATA-3 and their corresponding
cytokines.
Glucocorticoid suppression of inflammatory genes re-
quires, at least in part, recruitment of HDACs to the tran-
scriptional activation complex by the glucocorticoid
receptor [45]. We found that YGW had similar effects to
CORT, with a dose-dependent increase in HDAC activity
and reduction in HAT activity in an asthmatic mouse
model.
However, airway hyper-responsiveness or IgE levels,
which are valuable in the diagnosis of asthma and assess-
ment of its severity, were not measured in the mouse
model in this study.
Conclusion
Histone deacetylation of Tm was observed during allevi-
ation of asthma by YGW.
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